Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

EcoSynthetix Plans to Raise C$100 Million in Canadian IPO

July 11 (Bloomberg) -- EcoSynthetix Inc., a renewable chemicals company, plans to sell about C$100 million ($103 million) of shares in an initial public offering to finance research and development and expand production facilities.

The Burlington, Ontario-based company aims to sell 9.1 million to 11.1 million shares for between C$9 and C$11 each, according to sale documents obtained by Bloomberg News. The IPO is expected to be priced in the week of July 25, and the stock will be listed on the Toronto Stock Exchange under the symbol ECO.

EcoSynthetix specializes in biomaterials that can be used in industrial manufacturing to make products such as paint, paper and adhesives, according to a July 5 regulatory filing. The company said it developed processes that make lower-cost “green” alternatives to petroleum-based products using corn, potato, tapioca and other natural feedstocks.

The company was formed to buy a stake in Michigan-based EcoSynthetix U.S., which owns the assets including a research and development facility in Burlington and plants in Tennessee and The Netherlands.

UBS Securities Canada, Canaccord Genuity Corp. and RBC Capital Markets are leading a group of six banks on the sale. The underwriters have the option to sell another 15 percent after the sale closes.

A telephone message left with EcoSynthetix Chief Executive Officer John van Leeuwen wasn’t immediately returned.

To contact the reporter on this story: Doug Alexander in Toronto at

To contact the editor responsible for this story: David Scanlan at; David Scheer at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.